PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US
May 1, 2010, 00:00
10.1016/S1098-3015(10)72666-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)72666-8/fulltext
Title :
PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72666-8&doi=10.1016/S1098-3015(10)72666-8
First page :
Section Title :
Open access? :
No
Section Order :
214